相关实验视频

Updated: Jan 12, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

双面罩控制试验的H-1337作为治疗玻璃眼和眼睛高血压的治疗方法

Lee Shettle¹, Jay Mulaney², Robert D Williams³

¹Shettle Eye Research, Largo, Florida, USA.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

|November 4, 2025

概括

这项2B期研究评估了H-1337用于治疗青光瘤和眼高血压,发现它在降低眼内压力 (IOP) 方面与蒂莫洛尔相当,尽管没有达到严格的非劣势边际.

科学领域:

眼科医生眼科眼科
药理学药理学是指药理学的学科.
临床试验临床试验

背景情况:

玻璃眼和眼睛高血压是全球不可逆转失明的主要原因.
有效管理眼内压力 (IOP) 对于预防视神经损伤至关重要.

研究的目的:

评估H-1337.7的额外度和剂量频率.
为了比较H-1337的疗效和安全性与蒂摩洛尔马莱酸盐,一个积极的对照.

主要方法:

阶段2B,随机,双面罩,主控,剂量反应研究.
201名参与者患有开角玻璃眼或眼睛高血压.
在28天内用H-1337测量了24小时内心压力 (0.6%二日,1.0%二日,1.0%四日). 和提摩洛尔马莱酸0.5%两日一次.

主要成果:

H-1337显示了与蒂莫洛尔可比的眼部低血压疗效.
平均IOP降低范围为H-1337组的4-7 mmHg和蒂莫洛尔的5-8 mmHg.
高血压是最常见的不良事件,H-1337的发生频率高于提摩洛尔.

结论:

H-1337在降低内脏压力方面显示出与蒂莫洛尔相当的疗效.
非劣势差额未被严格遵守,可能是由于样本大小.
对于H-1337在青光眼治疗中的作用,可能需要进一步的研究.

关键词:

玻璃眼 glaucoma 玻璃眼玻璃眼玻璃眼玻璃眼眼内压力眼内压力眼睛高血压是什么意思罗基纳斯抑制剂罗基纳斯抑制剂

更多相关视频

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...